Ensuring the Biologic Safety of Plasma-Derived Therapeutic Proteins: Detection, Inactivation, and Removal of Pathogens

Author： Cai Kang Gierman Todd M. Hotta JoAnn Stenland Christopher J. Lee Douglas C. Pifat Dominique Y. Petteway Steve R.

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.19, Iss.2, 2005-01, pp. : 79-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Practical Considerations in Converting from Plasma-Derived to Recombinant Hepatitis B Vaccines

By Lee I. Lee C-Y.

BioDrugs, Vol. 10, Iss. 1, 1998-07 ,pp. : 11-25

Adis International

Access to resources Recommend Favorite

Prediction of Immunogenicity of Therapeutic Proteins: Validity of Computational Tools

By Bryson Christine J. Jones Tim D. Baker Matthew P.

BioDrugs, Vol. 24, Iss. 1, 2010-02 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite

Glycosylation of Therapeutic Proteins: An Effective Strategy to Optimize Efficacy

By Solá Ricardo J. Griebenow Kai

BioDrugs, Vol. 24, Iss. 1, 2010-02 ,pp. : 9-21

Adis International

Access to resources Recommend Favorite

Hot Ortho-Biologic Topics at AAOS 2011†: Platelet-Rich Plasma and Related Growth Factors Generate Excitement

By Hoggatt Julie

BioDrugs, Vol. 25, Iss. 3, 2011-06 ,pp. : 197-202

Adis International

Access to resources Recommend Favorite

Strategies for Targeting Tetraspanin Proteins: Potential Therapeutic Applications in Microbial Infections

By Hassuna Noha

BioDrugs, Vol. 23, Iss. 6, 2009-12 ,pp. : 341-359

Adis International

Access to resources Recommend Favorite